In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii
- 31 August 2005
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 52 (4), 317-322
- https://doi.org/10.1016/j.diagmicrobio.2005.03.003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strainJournal of Antimicrobial Chemotherapy, 2004
- Prevention of Resistance: A Goal for Dose Selection for Antimicrobial AgentsClinical Infectious Diseases, 2003
- Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibility.Journal of Antimicrobial Chemotherapy, 2000
- UREIDOPENICILLINS AND BETA-LACTAM/BETA-LACTAMASE INHIBITOR COMBINATIONSInfectious Disease Clinics of North America, 2000
- Characterization of a Nosocomial Outbreak Caused by a Multiresistant Acinetobacter baumannii Strain with a Carbapenem-Hydrolyzing Enzyme: High-Level Carbapenem Resistance inA. baumannii Is Not Due Solely to the Presence of β-LactamasesJournal of Clinical Microbiology, 2000
- Bacterial Resistance: A Worldwide ProblemDiagnostic Microbiology and Infectious Disease, 1998
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological featuresClinical Microbiology Reviews, 1996
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Significance of antimicrobial synergism for the outcome of gram negative sepsisThe American Journal of the Medical Sciences, 1977